The total issue size of Par Drugs IPO is up to ₹8.10 Cr whereas the issue size of the Parshva Enterprises IPO is up to ₹3.46 Cr. The final issue price of Par Drugs IPO is ₹51.00 per share and of Parshva Enterprises IPO is ₹45.00 per share.
Par Drugs IPO opens on May 03, 2019, while Parshva Enterprises IPO opens on Jun 19, 2019. The closing date of Par Drugs IPO and Parshva Enterprises IPO is May 08, 2019, and Jun 21, 2019, respectively.
In the Par Drugs IPO Retail Individual Investors (RII) are offered 7,80,000 shares while in Parshva Enterprises IPO retail investors are offered 7,80,000 shares. Qualified Institutional Buyers (QIB) are offered in Par Drugs IPO and in Parshva Enterprises IPO.